My Publications

Are losartan and imatinib effective against SARS-CoV2 pathogenesis?

A pathophysiologic-based in silico study. In Silico Pharmacol. 2021; 9, 1.

WHO ID: covidwho-962164

Erythropoietin and COVID-19-induced neuroinflammation;

EPO Plus Losartan Might be Promising. JBE. 2020; 6(2): 143-161

Losartan promotes cell survival following SARS-CoV-2 infection in vitro.

bioRxiv. 2021 Jan 1. WHO ID: ppbiorxiv-424507.